Trial Profile
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Dec 2017
Price :
$35
*
At a glance
- Drugs Naftifine (Primary)
- Indications Tinea cruris
- Focus Adverse reactions; Registrational
- Sponsors Merz Pharma
- 01 Feb 2014 New trial record